Valrelease

Valrelease Brand names, Valrelease Analogs

Valrelease Brand Names Mixture

No information avaliable

Valrelease Chemical_Formula

C₁₆H₁₃ClN₂O

Valrelease RX_link

http://www.rxlist.com/cgi/generic/diazepam.htm

Valrelease fda sheet

Valrelease msds (material safety sheet)

Valrelease MSDS

Valrelease Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Valrelease Molecular Weight

284.74 g/mol

Valrelease Melting Point

125-126^oC

Valrelease H₂O Solubility

Slightly soluble (50 mg/L)

Valrelease State

solid

Valrelease LogP

2.988

Valrelease Dosage Forms

Tablets; Injectable solution

Valrelease Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Valrelease Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Valrelease Absorption

Essentially complete, with a bioavailability of 93%.

Valrelease side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Valrelease Patient Information

Valrelease Organisms Affected

Humans and other mammals